RORγt inverse agonist 13 |
Catalog No.GC62349 |
RORγt 역 효능제 13(화합물 3i)은 63.8 nM의 IC50을 갖는 개선된 약물 유사 특성을 갖는 강력한 경구 활성 및 선택적 ROR&8#47;t 역 효능제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2170477-75-3
Sample solution is provided at 25 µL, 10mM.
RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist, with improved drug-like properties, with an IC50 of 63.8 nM[1].
RORγt inverse agonist 13 (Compound 3i) exhibits activity with an inhibition of 76% at 0.3 µM in Th17 cell differentiation assay[1].
RORγt inverse agonist 13 (Compound 3i, 25 mg/kg, Orally, twice daily) demonstrats excellent in vivo PK profile in mice and good in vivo efficacy in an IMQ-induced psoriasis mice model[1].
[1]. Nannan Sun, et al. Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists. Eur J Med Chem. 2020 Jul 5;202:112536.
Average Rating: 5
(Based on Reviews and 13 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *